<DOC>
	<DOCNO>NCT01725243</DOCNO>
	<brief_summary>In 2009 , Society Obstetricians Gynecologists Canada , produce national clinical guideline important woman 's health issue , recommend bolus carbetocin 100 mcg vein use elective cesarean delivery instead oxytocin infusion prevention bleed deliver baby . Similar oxytocin , carbetocin side effect dose-related . Although 100 mcg recommend dose , study nonlaboring woman suggest dos low 100 mcg may use achieve degree uterine contractility less side effect . So far , ideal dose use cesarean section labour woman failure progress labour ( failure cervix dilate adequately 10cm baby 's head descend birth canal ) determine . This study design determine minimum carbetocin dose require cesarean delivery 'failure progress ' achieve best effect .</brief_summary>
	<brief_title>Carbetocin Cesarean Delivery Labor Arrest</brief_title>
	<detailed_description>Post-partum hemorrhage ( PPH ) major cause maternal death worldwide . Oxytocin common uterotonic drug use prevent treat PPH North America , however , limitation use . Oxytocin short duration action , require continuous infusion achieve sustain uterotonic activity . The Society Obstetricians Gynecologists Canada ( SOGC ) recently recommend single 100mcg dose carbetocin elective Cesarean delivery promote uterine contraction prevent post partum hemorrhage ( PPH ) , lieu traditional oxytocin regimen . Carbetocin last 4 7 time longer oxytocin , similar side effect profile apparent great efficacy rate . The evidence report Carbetocin use literature mostly base upon low risk non-laboring patient undergo elective cesarean delivery . At present , 2 study look use Carbetocin low risk patient require emergency cesarean delivery . The minimum effective dose ( ED90 ) carbetocin labor woman determine far . Similar oxytocin , ED90 Carbetocin likely higher labor woman undergo Cesarean delivery compare non-laboring woman , due effect desensitization phenomenon . This study conduct prospective , randomize , up-down sequential allocation trial . The success fail patient study determine dose give future patient . Dosage increase patient follow failed case , keep patient follow successful case . Following successful case , also 1 9 chance dose decrease next patient . The result study establish minimum effective dose carbetocin uterine contraction cesarean delivery labor arrest . This likely minimize unnecessary side effect cause large bolus dose drug , improve quality safety patient care .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Carbetocin</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>All patient give write informed consent participate study . All patient plan uncomplicated low transverse cesarean delivery secondary labor arrest , epidural anesthesia . â‰¥37 week pregnancy Singleton pregnancy Patients receive oxytocin least 4 hour labor augmentation ASA 1 2 Refusal inability obtain informed consent . All patient claim allergy hypersensitivity oxytocin carbetocin . Previous history uterine atony PPH Risk factor PPH preeclampsia , polyhydramnios , uterine fibroid , bleed diathesis chorioamnionitis etc . Abnormal placental implantation ( know suspect ) &gt; 3 cesarean section past Previous classic uterine incision Macrosomia Estimated fetal weight &gt; 4500g Hemoglobin &lt; 100g/L Cesarean section general anesthesia ASA 3 4 patient hepatic , renal , cardiac ( eg . Coronary artery disease ) vascular disease Genital development problem ( eg . Abnormal uterus , cervix , vagina , etc . ) Uncontrolled hypotension hypertension Uncontrolled diabetes Abnormal heart rhythms bradycardia Drug abuser</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>pregnancy</keyword>
	<keyword>postpartum hemorrhage</keyword>
	<keyword>Cesarean delivery</keyword>
	<keyword>carbetocin</keyword>
	<keyword>failure progress labor</keyword>
</DOC>